Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition
Our understanding of severe acute respiratory syndrome coronavirus 2 breakthrough infections in Latin America is limited, specifically in regions with unique epidemiological dynamics. In this study, we fill a knowledge gap by characterizing these infections in Yucatán, Mexico, a major international travel hub with one of the world's most diverse vaccine rollouts, during the critical transition from the Delta variant to the Omicron variant. The translational importance of our investigation is twofold. First, through case-control data analysis, we provide robust, real-world evidence that vaccination significantly reduced the risk of hospitalization and death, offering crucial data to support ongoing vaccination campaigns against emerging variants. Second, by combining epidemiological data with phylodynamic analysis, we demonstrate a direct link between the easing of public health restrictions and the increased number and diversity of viral introductions that sparked the Omicron wave. This highlights the critical importance of coordinating genomic tracking with public health policy to mitigate the spread of future pandemic threats and strengthen global health security.
Authors
- Refugio González-Losa
- Pilar Granja-Pérez
- Samantha Fennessey (ORCID: https://orcid.org/0000-0001-7795-6439)
- Salha Villanueva-Jorge
- Guadalupe Ayora‐Talavera (ORCID: https://orcid.org/0000-0002-2829-6945)
- Irma López‐Martínez (ORCID: https://orcid.org/0000-0002-0538-474X)
- Nídia S. Trovão (ORCID: https://orcid.org/0000-0002-2106-1166)
- Laura Conde-Ferráez
- Sana Tamim
- Samia Kanwar
- Chelsea L. Hansen
- David J. Spiro
- Erin Yuan
- Gisela Barrea-Badillo
- André Corvelo
Institutions
- Roskilde University (DK)
- Aga Khan University (PK)
- National Institutes of Health (US)
- Harvard University Press (US)
- Secretaria de Salud (HN)
- Autonomous University of Yucatán (MX)
- Direccion General de Epidemiologia (MX)
- New York Genome Center (US)
- Fogarty International Center (US)
Publication Details
- Journal
- mBio
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1128/mbio.02432-25
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00